"Nitro Compounds" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds having the nitro group, -NO2, attached to carbon. When attached to nitrogen they are nitramines and attached to oxygen they are NITRATES.
| Descriptor ID |
D009574
|
| MeSH Number(s) |
D02.640
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nitro Compounds".
Below are MeSH descriptors whose meaning is more specific than "Nitro Compounds".
This graph shows the total number of publications written about "Nitro Compounds" by people in this website by year, and whether "Nitro Compounds" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 0 | 2 | 2 |
| 1994 | 0 | 1 | 1 |
| 1998 | 0 | 2 | 2 |
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 2 | 2 |
| 2002 | 1 | 5 | 6 |
| 2003 | 3 | 1 | 4 |
| 2004 | 5 | 6 | 11 |
| 2005 | 4 | 13 | 17 |
| 2006 | 10 | 4 | 14 |
| 2007 | 11 | 3 | 14 |
| 2008 | 13 | 3 | 16 |
| 2009 | 9 | 6 | 15 |
| 2010 | 5 | 7 | 12 |
| 2011 | 17 | 4 | 21 |
| 2012 | 13 | 3 | 16 |
| 2013 | 15 | 5 | 20 |
| 2014 | 17 | 5 | 22 |
| 2015 | 28 | 6 | 34 |
| 2016 | 23 | 9 | 32 |
| 2017 | 23 | 9 | 32 |
| 2018 | 14 | 5 | 19 |
| 2019 | 13 | 1 | 14 |
| 2020 | 2 | 1 | 3 |
| 2021 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Nitro Compounds" by people in Profiles.
-
Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trial. Eur Respir J. 2021 07; 58(1).
-
Available drugs and supplements for rapid deployment for treatment of COVID-19. J Mol Cell Biol. 2021 07 06; 13(3):232-236.
-
Role of nitazoxanide as a repurposed drug in the treatment and management of various diseases. Drugs Today (Barc). 2021 Jul; 57(7):455-473.
-
Development of a High-Throughput Screening Assay to Identify Inhibitors of the SARS-CoV-2 Guanine-N7-Methyltransferase Using RapidFire Mass Spectrometry. SLAS Discov. 2021 07; 26(6):749-756.
-
Effect of a combination of nitazoxanide, ribavirin, and ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID-19. J Med Virol. 2021 05; 93(5):3176-3183.
-
Therapeutic Potential of Nitazoxanide: An Appropriate Choice for Repurposing versus SARS-CoV-2? ACS Infect Dis. 2021 06 11; 7(6):1317-1331.
-
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis. Br J Clin Pharmacol. 2021 04; 87(4):2078-2088.
-
Desperate Times, Desperate Measures: The Case for RRx-001 in the Treatment of COVID-19. Semin Oncol. 2020 10; 47(5):305-308.
-
p-Hole Interactions Involving Nitro Aromatic Ligands in Protein Structures. Chemistry. 2019 Oct 17; 25(58):13436-13443.
-
Efficacy of imidacloprid 10%/moxidectin 2.5% spot on (Advocate®, Advantage Multi®) and doxycycline for the treatment of natural Dirofilaria immitis infections in dogs. Vet Parasitol. 2019 Sep; 273:11-16.